The Effectiveness of Post-Vaccination and Post-Infection Protection in the Hospital Staff of Three Prague Hospitals: A Cohort Study of 8-Month Follow-Up from the Start of the COVID-19 Vaccination Campaign (COVANESS)

被引:4
|
作者
Petras, Marek [1 ]
Lesna, Ivana Kralova [2 ,3 ,4 ]
Vecerova, Livia [5 ]
Nycova, Elka [5 ]
Malinova, Jana [6 ]
Klezl, Petr [6 ]
Nezvedova, Martina [6 ]
White, Rachel Elizabeth [6 ]
Macalik, Roman [1 ]
Danova, Jana [1 ]
Celko, Alexander M. [1 ]
Adamkova, Vera [2 ]
机构
[1] Charles Univ Prague, Fac Med 3, Prague 10000, Czech Republic
[2] Inst Clin & Expt Med, Prague 14021, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Prague 12108, Czech Republic
[4] Mil Univ Hosp, Prague 12108, Czech Republic
[5] Bulovka Univ Hosp, Prague 18000, Czech Republic
[6] Kralovske Vinohrady Univ Hosp, Prague 10034, Czech Republic
关键词
effectiveness; COVID-19; vaccination; hospital workers; reinfection; breakthrough infection; SARS-COV-2; INFECTION;
D O I
10.3390/vaccines10010009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Continuous assessment of the effectiveness of approved COVID-19 vaccines is crucial to gain an insight into the longer-term impact on health outcomes, and eventually boosting public confidence. For this reason, we conducted a multicenter, retrospective cohort study using data on infection and vaccination rates among employees of three Prague hospitals in the period between 27 December 2020 and 31 August 2021. The post-vaccination and post-infection protectiveness were assessed in a total of 11,443 hospital workers who were followed up for more than 14 days either after their Comirnaty vaccination or study enrolment, depending on their previous SARS-CoV-2 infection. The effectiveness of full vaccination against any SARS-CoV-2 infection achieved 88.3% (83.2-91.8%) over the eight months of follow-up, a figure not much different from the 92.5% (76.5-97.6%) level of protection built by a previous infection. Despite this, the post-vaccination level of protection declined to about 65% between June and August. No case of breakthrough infection was registered among hospital workers having received one or two vaccine doses more than three months after previous infection. The eight-month effectiveness of the Comirnaty vaccine exhibited a declining trend requiring a new booster dose. The need for vaccination in the previously infected employees was not demonstrated conclusively in this study.
引用
收藏
页数:12
相关论文
共 15 条
  • [1] Changes in COVID-19 measures in the workplace: 8-month follow-up in a cohort study of full-time employees in Japan
    Asaoka, Hiroki
    Sasaki, Natsu
    Imamura, Kotaro
    Kuroda, Reiko
    Tsuno, Kanami
    Kawakami, Norito
    JOURNAL OF OCCUPATIONAL HEALTH, 2021, 63 (01)
  • [2] Post-vaccination infection rates and modification of COVID-19 symptoms in vaccinated UK school-aged children and adolescents: A prospective longitudinal cohort study
    Molteni, Erika
    Canas, Liane S.
    Kla, Kerstin
    Deng, Jie
    Bhopal, Sunil S.
    Hughes, Robert C.
    Chen, Liyuan
    Murray, Benjamin
    Kerfoot, Eric
    Antonelli, Michela
    Sudre, Carole H.
    Pujol, Joan Capdevila
    Polidori, Lorenzo
    May, Anna
    Hammers, Prof Alexander
    Wolf, Jonathan
    Spector, Prof Tim D.
    Steves, Claire J.
    Ourselin, Prof Sebastien
    Absoud, Michael
    Modat, Marc
    Duncan, Prof Emma L.
    LANCET REGIONAL HEALTH-EUROPE, 2022, 19
  • [3] IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study
    Gil-Manso, Sergio
    Alonso, Roberto
    Catalan, Pilar
    Sanchez-Arcilla, Ignacio
    Marzola, Marco
    Correa-Rocha, Rafael
    Pion, Marjorie
    Munoz, Patricia
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [4] Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic
    Anne-Françoise Rousseau
    Pauline Minguet
    Camille Colson
    Isabelle Kellens
    Sourour Chaabane
    Pierre Delanaye
    Etienne Cavalier
    J. Geoffrey Chase
    Bernard Lambermont
    Benoit Misset
    Annals of Intensive Care, 11
  • [5] Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic
    Rousseau, Anne-Francoise
    Minguet, Pauline
    Colson, Camille
    Kellens, Isabelle
    Chaabane, Sourour
    Delanaye, Pierre
    Cavalier, Etienne
    Chase, J. Geoffrey
    Lambermont, Bernard
    Misset, Benoit
    ANNALS OF INTENSIVE CARE, 2021, 11 (01)
  • [6] Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study
    Yamamoto, Shohei
    Maeda, Kenji
    Matsuda, Kouki
    Tanaka, Akihito
    Horii, Kumi
    Okudera, Kaori
    Takeuchi, Junko S.
    Mizoue, Tetsuya
    Konishi, Maki
    Ozeki, Mitsuru
    Sugiyama, Haruhito
    Aoyanagi, Nobuyoshi
    Mitsuya, Hiroaki
    Sugiura, Wataru
    Ohmagari, Norio
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E683 - E691
  • [7] Comments on "Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up" by De Michele et al. Cardiopulmonary impairment related to the ARDS-COVID-19: insights about monitoring post-infection recovery
    Ruggeri, Paolo
    Nair, Abhijit S.
    Esquinas, Antonio
    MONALDI ARCHIVES FOR CHEST DISEASE, 2022, 92 (04)
  • [8] Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up
    Tleyjeh, Imad M.
    Saddik, Basema
    AlSwaidan, Nourah
    AlAnazi, Ahmed
    Ramakrishnan, Rakhee K.
    Alhazmi, Deema
    Aloufi, Ahmad
    AlSumait, Fahad
    Berbari, Elie
    Halwani, Rabih
    PLOS ONE, 2021, 16 (12):
  • [9] New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort
    Gasparotto, M.
    Bindoli, S.
    Padoan, R.
    Cozzi, G.
    Depascale, R.
    Zanatta, E.
    Giollo, A.
    Gatto, M.
    Zen, M.
    Schiavon, F.
    Ramonda, R.
    Sfriso, P.
    Doria, A.
    Iaccarino, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (03) : 642 - 648
  • [10] Post-discharge quality of life of COVID-19 patients at 1-month follow-up: A cross-sectional study in the largest tertiary care hospital of Bangladesh
    Hoque, Mohammad Mahfuzul
    Datta, Ponkaj Kanti
    Basu, Kamalesh Chandra
    Rahman, Muhammad Faizur
    Khan, Mohammed Masudul Hassan
    Kamal, Mohammad Mostafa
    Mahmud, Reaz
    Aftab, Kazi Ali
    Khan, Ejrarul Alam
    Mahmud, Imran
    Sharmin, Rumana
    Khan, Md. Abdullah Saeed
    Hasan, Mohammad Jahid
    Amin, Md. Robed
    Miah, Md. Titu
    Rahman, Md. Mujibur
    PLOS ONE, 2023, 18 (01):